Condition: Dry Eye · Meibomian Gland Dysfunction · Sponsor: University of California, Berkeley
The purpose of this study is to examine the impact of nasal spray treatment on Meibomian gland function and ocular surface health in symptomatic dry eye patients with mild to moderate Meibomian gland dysfunction (MGD).
This description comes directly from the study's public registry record.
Meng C. Lin, OD, PhD · 510-643-9252 · mlin@berkeley.edu
Laimeng Lee, OD, MS · 510-643-9252 · laimenglee@berkeley.edu
Always discuss trial participation with your own doctor first.
| U.C. Berkeley Clinical Research Center | Berkeley, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07606625